Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2009
10/28/2009CN100554280C Plant ERF transcription factor, encoding gene and application thereof
10/28/2009CN100553682C G type non-viral vector and pharmaceutical composition containing same
10/27/2009USRE40948 APC antibodies
10/27/2009US7610154 Method and apparatus for chemical genetic programming
10/27/2009US7608763 Plants and seeds of hybrid corn variety CH100833
10/27/2009US7608762 Plants and seeds of hybrid corn variety CH788706
10/27/2009US7608759 Scarecrow-like stress-related polypeptides and methods of use in plants
10/27/2009US7608758 Plant system for comprehensive gene function analysis with the use of full-length cDNA
10/27/2009US7608757 Transgenic drought resistant plants; crops with enhanced resistance to enviromental stresses
10/27/2009US7608756 introducing into a plant cell a chimeric gene comprising an isolated promoter region that controls epidermis-specific expression operably linked to the desired coding sequence, said promoter region comprising a first sequence originating from the promoter of a GSTA1 and 2nd from intron of a WIR1 genes
10/27/2009US7608755 Used to modulate the phytic acid biosynthesis in such a way as to decrease phytate and/or increase non-phytate phosphorous, especially in corn or soy animal feedstuffs
10/27/2009US7608754 Using trangenic dicots to produce trisaccharide 1-kestose with low degree of polymerization; forming low caloric sweeteners in plants
10/27/2009US7608753 Nucleotide sequences coding polyunsaturated fatty acid polyketide synthase of schizochytrium for use in preparation and delivery of therapeutic pharmaceuticals for treatment of bone, neurodegenerative inflammatory and cell proliferative diseases
10/27/2009US7608752 Gene targeting using replicating DNA molecules
10/27/2009US7608751 Fungus resistant plants and their uses
10/27/2009US7608750 Nonhuman model animal unresponsive to immunopotentiating synthetic compound
10/27/2009US7608749 Monitoring APP cleavage in transgenic rodents comprising an APP Swedish mutation
10/27/2009US7608708 Monocotyledon plant cells and plants which synthesize modified starch
10/27/2009US7608707 siRNA targeting survivin
10/27/2009US7608706 An siRNA molecule consisting of a sense region and an antisense region which together form a duplex region consisting of 19-30 base pairs and the antisense region comprises a sequence complementing SEQ ID NO: 449; having either no overhang regions or one or more; increasing the efficiency of RNAi
10/27/2009US7608705 Oligonucleotides, agents containing these oligonucleotides, and the use thereof
10/27/2009US7608704 Isolated polynucleotide encoding a polypeptide having preprosecretin activity and the amino acid sequence of SEQ ID NO:6; genetic engineering; cell cultures; antiproliferative agents; autoimmune diseases; antiinflammatory agents; cardiovascular/ nervous system/ developmental/gene expression disorders
10/27/2009US7608703 Nucleic acid with acyl transferase activity; vectors, host cells; biosynthesis of polyunsaturated fatty acid (PUFA)
10/27/2009US7608702 PUFA polyketide synthase systems and uses thereof
10/27/2009US7608701 Corticotropin releasing factor 2 receptor agonists
10/27/2009US7608700 Lactobacillus acidophilus nucleic acid sequences encoding stress-related proteins and uses therefor
10/27/2009US7608698 Muscular disorders; cardiovascular disorders; cell transformed with nucleic acid; culture product
10/27/2009US7608697 Mixture comprising enzymatic polypeptides with proline modified terminal for use in enhancing/reducing digestion/flavor/bitterness of foods; food processing
10/27/2009US7608696 Immunoglobulin for use in diagnosis and prognosis of metastatic breast cancer and degenerative neural conditions; drug screening; immunotherapy and diagnostics; anticarcinogenic agents
10/27/2009US7608694 Neutralizing antibody with specificity for antigenic determinants; infections (viral, bacterial, fungal and parasitic), endotoxic shock associtated with infection, arthritis, rheumatoid arthritis, pelvic inflammatory disease, Alzheimer's Disease, Crohn's disease
10/27/2009US7608691 Antibodies against IL-16 antagonist peptides
10/27/2009US7608690 IL-B30 antibodies
10/27/2009US7608686 Ztnfr12 polypeptides and Ztnfr12 fusion proteins
10/27/2009US7608683 Human leukocyte antigen pan DR-binding peptides for use in the treatment of infections, inflammatory, autoimmune and cancer diseases; has heat shock protein that is capable of binding to MHC class II molecules
10/27/2009US7608681 Methods and compositions for prolonging elimination half-times of bioactive compounds
10/27/2009US7608452 Polynucleotides encoding cytokine receptor zcytor19
10/27/2009US7608451 Expression vector comprising kinase nucleotide sequence for use as tool in transformation and expression of heterologus genes in mamalian cells
10/27/2009US7608450 Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
10/27/2009US7608449 Methods and compositions related to high-titer pseudotyped retroviruses
10/27/2009US7608448 Plasmid for transferring genetic information into prokaryotic gene sequences/operons using directed homologous recombination
10/27/2009US7608445 Increased activity and stability at increased pH and temperature
10/27/2009US7608443 Lysophosphatidic acid acetyltransferases
10/27/2009US7608442 Obtained from Campylobacter species; for use in synthesis of lipooligosaccharide (LOS); ganglioside biosynthesis and mimetics for treatment of nervous system disorders
10/27/2009US7608437 Producing coryneform bacteria with an improved amino acid or nucleic acid productivity by introducing a mutation in a promoter sequence of biosynthesizing genes on a chromosome of a coryneform bacterium so that it is close to a consensus sequence; high yields; producing L-glutamic acid
10/27/2009US7608435 Microorganism producing 5′-xanthylic acid
10/27/2009US7608434 Modified at an amino acid position 41, 42, 450, or 454; greater avidity; low mobility level within the cell
10/27/2009US7608432 Method for producing purine nucleoside by fermentation
10/27/2009US7608431 High concentration, high average sialic acid content per EPO molecule
10/27/2009US7608430 Fusion protein; multimeric protein; treating interferon gamma -related conditions
10/27/2009US7608428 Polynucleotide encoding an IL-28B polypeptide
10/27/2009US7608427 Encoding polypeptide covalently attached with a polyethylene glycol propionaldehyde group having anti-hepatitis C activity
10/27/2009US7608426 Nucleotide sequences coding for interleukin polypeptide for use as tool in tissue repair
10/27/2009US7608425 For increasing the longevity of a cell culture and permitting the increased production of recombinant proteins; culturing
10/27/2009US7608424 Process for production of a recombinant protein and a fusion protein
10/27/2009US7608423 Expanding the eukaryotic genetic code
10/27/2009US7608422 Gene therapy; vaccines; inducing antibodies and/or cytotoxic or helper T lymphocytes
10/27/2009US7608410 Method of improving T cell receptors
10/27/2009US7608409 Screening assay using G-protein coupled receptor protein OT7T175
10/27/2009US7608401 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis
10/27/2009US7608398 Minimally cross-hybridizing nucleotide sequences; provides of a family of molecules which is sufficiently large and where each individual member is sufficiently selective for its complement over all the other zipcode molecules
10/27/2009US7608288 Caffeine fraction obtained from tea leaves and a method for inducing Agrobacterium tumefaciens-mediated genetic transformation in plants using said caffeine fraction
10/27/2009US7608276 vaccines, immunogenic compositions; diagnostics, enzymatic studies and targets for antibiotics; for treating Staphylococcus aureus infection
10/27/2009US7608273 glycoprotein cationic polypeptide as HIV vaccines; nontoxic
10/27/2009US7608269 Compositions and methods for treating cancer by modulating HER-2 and EGF receptors
10/27/2009US7608268 Ferritin fusion proteins for use in vaccines and other applications
10/27/2009US7608257 Using a reovirus and chemotherapeutic agents to treat ras-activated neoplastic cells; proliferative disorders
10/27/2009US7608255 Replication-competent anti-cancer vectors
10/27/2009CA2390867C Method for the production of biopolymers with modified properties
10/27/2009CA2372085C L-ribo-lna analogues
10/27/2009CA2349529C Pge synthase and methods and means for modulating its activity
10/27/2009CA2328904C Novel (poly)peptides which represent the epitopes of the human herpesvirus type 8
10/27/2009CA2327547C Oligonucleotides containing pyrazolo[3,4-d]pyrimidines for hybridization and mismatch discrimination
10/27/2009CA2230967C Improved nucleic acid assays
10/27/2009CA2226397C Genes for mutant microsomal delta-12 fatty acid desaturases and related enzymes from plants
10/27/2009CA2224143C Recombinant hexose oxidase, a method of producing same and use of such enzyme
10/27/2009CA2202154C Methods for drug screening
10/27/2009CA2163364C Self-assembling polynucleotide delivery system comprising dendrimer polycations
10/27/2009CA2148492C Bovine heat shock promoter and uses thereof
10/27/2009CA2146145C Immunogenic meningococcal lps and outer membrane vesicles and vaccine therefrom
10/22/2009WO2009129549A2 Babesia microti genomic clones containing novel antigens useful in the diagnosis of babesiosis
10/22/2009WO2009129544A1 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
10/22/2009WO2009129524A2 High-throughput plasmid dna preparation
10/22/2009WO2009129523A2 Compositions and methods for nucleic acid delivery
10/22/2009WO2009129505A2 Compositions, methods, and kits using synthetic probes for determining the presence of a target nucleic acid
10/22/2009WO2009129465A2 Compositions and methods for inhibiting expression of xbp-1 gene
10/22/2009WO2009129424A2 Longevity-promoting effects of acetic acid and reishi polysaccharide
10/22/2009WO2009129319A2 Silencing of csn5 gene expression using interfering rna
10/22/2009WO2009129263A1 Peptides promoting lipid efflux via abca1 and activating a lipoprotein lipase
10/22/2009WO2009129250A2 Meal-time insulin analogues of enhanced stability
10/22/2009WO2009129247A2 Sequence diversity generation in immunoglobulins
10/22/2009WO2009129162A2 Methods and compositions for increasing plant disease resistance and yield
10/22/2009WO2009128953A2 Genetic variants in a hypertension susceptibility gene stk39 and uses thereof
10/22/2009WO2009128949A2 Compositions of dengue viral proteins and methods of use
10/22/2009WO2009128911A2 Genetics variants associated with hiv disease restriction
10/22/2009WO2009128734A1 Marker assisted identification of mammals for desired phenotypic trait
10/22/2009WO2009128683A2 Method for constructing a viral genomic library from the state in which viruses are mixed with the infected hosts
10/22/2009WO2009128649A2 Method of separating and purifying cellular components using non-covalent bond between cucurbituril derivative and guest compound and apparatus using the same
10/22/2009WO2009128526A1 Apparatus for the identification of ribonucleic acid, method for the identification of ribonucleic acid and program and system for the identification of ribonucleic acid
10/22/2009WO2009128453A1 Proliferative disease detection method
10/22/2009WO2009128448A1 Novel protein capable of binding to hyaluronic acid, and method for measurement of hyaluronic acid using the same